DNA/GENE MICROARRAY MARKET ANALYSIS

DNA/Gene Microarray Market, By Type (Oligonucleotide DNA Microarrays, Complementary DNA Microarrays),By Application (Genomics, Proteomics, Agricultural Biology, Environment, Drug Research and Development, Cancer/oncology, Others (SNP Analysis, etc.)),By End User (Biopharmaceutical and Pharmaceutical Companies, Diagnostic Laboratories, Research Laboratories, Others (Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Global DNA/Gene Microarray Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global DNA/gene microarray market over the forecast period. North America is estimated to hold 33.5% of the market share in 2023. The global DNA/gene microarray market is expected to witness significant growth in the coming years, owing to increasing product launches by key market players. For instance, in March 2020, Agilent Technologies Inc. announced the launch of Agilent GenetiSure Cyto microarrays for prenatal and postnatal research. The new Agilent GenetiSure Cyto microarrays include updated, clinically relevant content from respected databases. The probes on the Cyto microarrays provide high-resolution detection of copy number variations and copy-neutral loss of heterozygosity associated with developmental delay, neuropsychiatric disorders, intellectual disability, congenital anomalies, or unexplained dysmorphic features in constitutional DNA samples.

DNA/Gene Microarray Market Report Snapshots